Pharmagest Interactive
Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare p… Read more
Market Cap & Net Worth: Pharmagest Interactive (0R9T)
Pharmagest Interactive (LSE:0R9T) has a market capitalization of $541.73 Million (€527.76 Million) as of March 19, 2026. Listed on the LSE stock exchange, this UK-based company holds position #15660 globally and #311 in its home market, demonstrating a -6.24% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmagest Interactive's stock price €35.30 by its total outstanding shares 14950700 (14.95 Million).
Pharmagest Interactive Market Cap History: 2016 to 2026
Pharmagest Interactive's market capitalization history from 2016 to 2026. Data shows growth from $360.76 Million to $541.73 Million (4.97% CAGR).
Pharmagest Interactive Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmagest Interactive's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.12x
Pharmagest Interactive's market cap is 3.12 times its annual revenue
Latest Price to Earnings (P/E) Ratio
18.70x
Pharmagest Interactive's market cap is 18.70 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $360.76 Million | $128.38 Million | $20.57 Million | 2.81x | 17.54x |
| 2017 | $594.94 Million | $129.67 Million | $23.14 Million | 4.59x | 25.72x |
| 2018 | $732.11 Million | $148.48 Million | $25.43 Million | 4.93x | 28.79x |
| 2019 | $859.98 Million | $158.57 Million | $28.40 Million | 5.42x | 30.28x |
| 2020 | $1.59 Billion | $171.75 Million | $30.71 Million | 9.25x | 51.75x |
| 2021 | $1.38 Billion | $193.07 Million | $39.12 Million | 7.12x | 35.16x |
| 2022 | $1.11 Billion | $214.07 Million | $46.38 Million | 5.19x | 23.96x |
| 2023 | $916.55 Million | $219.79 Million | $47.05 Million | 4.17x | 19.48x |
| 2024 | $676.78 Million | $216.80 Million | $36.20 Million | 3.12x | 18.70x |
Competitor Companies of 0R9T by Market Capitalization
Companies near Pharmagest Interactive in the global market cap rankings as of March 19, 2026.
Key companies related to Pharmagest Interactive by market ranking:
- Tongxing Environmental Protection (SHE:003027): Ranked #15651 globally with a market cap of $177.45 Million USD ( CN¥1.30 Billion CNY).
- Magnum Bhd (KLSE:3859): Ranked #15652 globally with a market cap of $177.41 Million USD ( RM799.07 Million MYR).
- Xiangtan Yongda Mach Mnfg Co (SHE:001239): Ranked #15661 globally with a market cap of $177.08 Million USD ( CN¥1.30 Billion CNY).
- Utah Medical Products Inc (NASDAQ:UTMD): Ranked #15662 globally with a market cap of $177.03 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #15651 | Tongxing Environmental Protection | SHE:003027 | $177.45 Million | CN¥22.40 |
| #15652 | Magnum Bhd | KLSE:3859 | $177.41 Million | RM1.26 |
| #15661 | Xiangtan Yongda Mach Mnfg Co | SHE:001239 | $177.08 Million | CN¥16.25 |
| #15662 | Utah Medical Products Inc | NASDAQ:UTMD | $177.03 Million | $64.05 |
Pharmagest Interactive Historical Marketcap From 2016 to 2026
Between 2016 and today, Pharmagest Interactive's market cap moved from $360.76 Million to $ 541.73 Million, with a yearly change of 4.97%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €541.73 Million | -21.47% |
| 2025 | €689.82 Million | +1.93% |
| 2024 | €676.78 Million | -26.16% |
| 2023 | €916.55 Million | -17.52% |
| 2022 | €1.11 Billion | -19.20% |
| 2021 | €1.38 Billion | -13.48% |
| 2020 | €1.59 Billion | +84.83% |
| 2019 | €859.98 Million | +17.47% |
| 2018 | €732.11 Million | +23.06% |
| 2017 | €594.94 Million | +64.91% |
| 2016 | €360.76 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Pharmagest Interactive was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $541.73 Million USD |
| MoneyControl | $541.73 Million USD |
| MarketWatch | $541.73 Million USD |
| marketcap.company | $541.73 Million USD |
| Reuters | $541.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.